Clinical Outcomes in Patients Treated With SternaLock Blu

Zimmer Biomet156 enrolled

Overview

The primary objective of this study is to evaluate the rate of deep sternal wound infection at 30 days post-operative following a full median sternotomy in patients treated with SternaLock Blu for rigid sternal fixation. This study will also provide evidence of the clinical performance of SternaLock Blu for up to 90 days using real world evidence methodology. Sternal complications will be reported through 90 days follow up.

The primary endpoint for this study is the rate of deep sternal wound infection (DSWI) at 30 days post-operative, following a midline sternotomy closed with SternaLock Blu. DSWI is defined as deep infection involving muscle, bone, and/ or mediastinum requiring operative intervention and has all of the following conditions: 1. Wound opened with excision of tissue or re-exploration of mediastinum 2. Positive culture unless patient on antibiotics at the time of culture or no culture obtained 3. Treatment with antibiotics beyond perioperative prophylaxis Post-operative sternal wound complications occurring within 90 days post-operative. Outcomes will be reported up to 90 days after surgery, including data on adverse events associated with the use of SternaLock Blu Sternal Closure System from the moment of implantation to the end-of-study.

Study Type

OBSERVATIONAL

Enrollment

156

Conditions

Cardiac Surgical Procedures Coronary Artery Disease Heart Valve Diseases

Interventions

SternaLock BluDEVICE

Sternal closure will be accomplished using SternaLock Blu plates and screws in combination with single-wire method of sternal reduction.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. ≥ 18 years of age, no upper limit 2. Undergoing a full standard midline sternotomy as part of an elective or urgent cardiac surgical procedure \[i.e., coronary artery bypass graft (CABG) and/ or valve replacement along with other cardiac surgical procedures\] and closed with the SternaLock Blu Sternal Closure System 3. Willing and able to return for follow-up Exclusion Criteria: Preoperative 4. Emergent or salvage cardiac acuity i.e., patients undergoing cardiopulmonary resuscitation en-route to the operating room or prior to induction of anesthesia 5. Any contraindication listed in the SternaLock Blu instructions for use (IFU/ Appendix 3) (active infection, foreign body sensitivity, or mental/ neurologic conditions who are unwilling or incapable of following post-operative care instructions) Operative 6. Delayed sternal closure required for any reason 7. Intra-operative conditions that, in the opinion of the operating surgeon, would preclude the use of rigid plate fixation, i.e.: insufficient quantity of sternal bone or compressible sternum indicating poor bone quality, as assessed by the operating surgeon using his or her professional judgment at the time of closure 8. Use of bone wax between the sternal halves 9. Intraoperative death prior to device placement

Locations (4)

St. Franciscan Health

Indianapolis, Indiana, United States

Saint Luke's Hospital of Kansas City

Kansas City, Missouri, United States

Cardiovascular Surgery Clinic, PLLC

Memphis, Tennessee, United States

University of Virginia

Charlottesville, Virginia, United States

Outcomes

Primary Outcomes

Deep Sternal Wound Infection Rate

DSWI is defined as deep infection involving muscle, bone, and/ or mediastinum requiring operative intervention and has all of the following conditions: 1. Wound opened with excision of tissue (I\&D) or re-exploration of mediastinum 2. Positive culture unless patient on antibiotics at the time of culture or no culture obtained 3. Treatment with antibiotics beyond perioperative prophylaxis

Time frame: at 30 days post operatively up to 90 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.